2010
DOI: 10.3892/ijo_00000547
|View full text |Cite
|
Sign up to set email alerts
|

Chronologic aging decreases tumor angiogenesis and metastasis in a mouse model of head and neck cancer

Abstract: Abstract. The incidence of malignant tumors increases with age. This may be due to the duration of carcinogenesis or age related changes providing a favorable environment for tumor formation. Aging is associated with molecular, cellular and physiological events that influence carcinogenesis and cancer growth. Physiologic cell proliferation, differentiation, and aging can result in cell death. However, under the influence of exogenous or endogenous factors cells can undergo pathologic dedifferentiation, immorta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 24 publications
(24 reference statements)
0
1
0
Order By: Relevance
“…The physiological differences between young and old animals are significant, and one example is related to the EPR effect. Tumor-bearing young animals may exhibit a more pronounced EPR effect than older animals since older subjects present a lower tumor angiogenesis rate ( 31 ). This issue makes less probable the formation of blood vessels with fenestrations allowing the higher permeation of nanocarriers by tumor tissues in young animals compared to older subjects ( 32 ).…”
Section: Considerations About Preclinical Studies Of Nanocarriersmentioning
confidence: 99%
“…The physiological differences between young and old animals are significant, and one example is related to the EPR effect. Tumor-bearing young animals may exhibit a more pronounced EPR effect than older animals since older subjects present a lower tumor angiogenesis rate ( 31 ). This issue makes less probable the formation of blood vessels with fenestrations allowing the higher permeation of nanocarriers by tumor tissues in young animals compared to older subjects ( 32 ).…”
Section: Considerations About Preclinical Studies Of Nanocarriersmentioning
confidence: 99%